Cargando…

Distinct gut microbial compositional and functional changes associated with impaired inhibitory control in patients with cirrhosis

Most cirrhosis etiologies, such as alcohol, hepatitis C, and obesity, involve behavior that require the loss of inhibitory control. Once cirrhosis develops, patients can also develop cognitive impairment due to minimal hepatic encephalopathy (MHE). Both processes could have distinct imprints on the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bajaj, Jasmohan S, Shamsaddini, Amirhossein, Fagan, Andrew, McGeorge, Sara, Gavis, Edith, Sikaroodi, Masoumeh, Brenner, Lisa A., Wade, James B, Gillevet, Patrick M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344770/ https://www.ncbi.nlm.nih.gov/pubmed/34346283 http://dx.doi.org/10.1080/19490976.2021.1953247

Ejemplares similares

Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials
por: Bajaj, Jasmohan S., et al.
Publicado: (2020)

Multiple bacterial virulence factors focused on adherence and biofilm formation associate with outcomes in cirrhosis
por: Bajaj, Jasmohan S, et al.
Publicado: (2021)

Area Deprivation Index and Gut-Brain Axis in Cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2022)

Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis
por: Ahluwalia, Vishwadeep, et al.
Publicado: (2016)

Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus
por: Bajaj, Jasmohan S., et al.
Publicado: (2015)

Erratum: Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus
por: Bajaj, Jasmohan S., et al.
Publicado: (2016)

Elderly patients have an altered gut-brain axis regardless of the presence of cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2016)

Substance‐use simulation impairs driving capability in patients with cirrhosis regardless of hepatic encephalopathy
por: Acharya, Chathur, et al.
Publicado: (2022)

Hepatic Branch Vagotomy Modulates the Gut-Liver-Brain Axis in Murine Cirrhosis
por: Zhang, Yuan, et al.
Publicado: (2021)

Perspectives of Inpatients With Cirrhosis and Caregivers on Using Health Information Technology: Cross-sectional Multicenter Study
por: Acharya, Chathur, et al.
Publicado: (2021)

Serum and urinary metabolomics and outcomes in cirrhosis
por: Bajaj, Jasmohan S., et al.
Publicado: (2019)

Mindfulness-Based Stress Reduction Therapy Improves Patient and Caregiver-Reported Outcomes in Cirrhosis
por: Bajaj, Jasmohan S, et al.
Publicado: (2017)

Gut Microbiota as Biosensors in Patients With Cirrhosis
por: Bajaj, Jasmohan S.
Publicado: (2019)

Gut microbial composition can differentially regulate bile acid synthesis in humanized mice
por: Kang, Dae Joong, et al.
Publicado: (2017)

A specialized HE testing clinic improves rational decision-making for therapy in cirrhosis
por: Nadeem, Mahum, et al.
Publicado: (2023)

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
por: Bajaj, Jasmohan S., et al.
Publicado: (2013)

Reduced alcohol preference and intake after fecal transplant in patients with alcohol use disorder is transmissible to germ-free mice
por: Wolstenholme, Jennifer T., et al.
Publicado: (2022)

Gut microbiota manipulation during the prepubertal period shapes behavioral abnormalities in a mouse neurodevelopmental disorder model
por: Saunders, Justin M., et al.
Publicado: (2020)

BiomMiner: An advanced exploratory microbiome analysis and visualization pipeline
por: Shamsaddini, Amirhossein, et al.
Publicado: (2020)

Subjective and objective burden on providers from a multicenter app-based study of patients with cirrhosis and caregivers
por: Shaw, Jawaid, et al.
Publicado: (2023)

Cirrhosis, bile acids and gut microbiota: Unraveling a complex relationship
por: Ridlon, Jason M, et al.
Publicado: (2013)

Temporal Study of the Microbial Diversity of the North Arm of Great Salt Lake, Utah, U.S.
por: Almeida-Dalmet, Swati, et al.
Publicado: (2015)

Whoop there it is: decoding sleep, cirrhosis, and HE
por: Badal, Bryan D., et al.
Publicado: (2023)

Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues
por: Montagnese, Sara, et al.
Publicado: (2019)

Gut microbiome identifies risk for colorectal polyps
por: Dadkhah, Ezzat, et al.
Publicado: (2019)

Effect of Increasing Age on Brain Dysfunction in Cirrhosis
por: Liu, Runping, et al.
Publicado: (2018)

Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment
por: Hassouneh, Ramzi, et al.
Publicado: (2021)

The Presence of Denitrifiers In Bacterial Communities of Urban Stormwater Best Management Practices (BMPs)
por: Hall, Natalie C., et al.
Publicado: (2021)

The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics
por: Ridlon, Jason M., et al.
Publicado: (2015)

Transmitting Diet‐Related Microbial Benefit through Fecal Microbiota Transplant in NASH: Can Microbiota Cut Through the Fat?
por: Acharya, Chathur, et al.
Publicado: (2020)

Variability and Lability of Ammonia Levels in Healthy Volunteers and Patients With Cirrhosis: Implications for Trial Design and Clinical Practice
por: Bajaj, Jasmohan S., et al.
Publicado: (2019)

Quorum-Sensing Dysbiotic Shifts in the HIV-Infected Oral Metabiome
por: Brown, Robert E., et al.
Publicado: (2015)

Optimization of tissue sampling for Borrelia burgdorferi in white-footed mice (Peromyscus leucopus)
por: Zawada, Sonya G., et al.
Publicado: (2020)

Genetic variation of Borreliella burgdorferi in Fairfax County, Virginia, targeting the OspC gene in white-footed mice
por: Zawada, Sonya G., et al.
Publicado: (2022)

Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors
por: Williams, Sydni, et al.
Publicado: (2021)

Targeting Gut Microbiome Interactions in Service-Related Gastrointestinal and Liver Diseases of Veterans
por: Bajaj, Jasmohan S., et al.
Publicado: (2019)

Sa1372: TRACKING CIRRHOSIS CARE DURING COVID-19 PANDEMIC
por: Adejumo, Adeyinka C., et al.
Publicado: (2022)

Tu1264: PATIENTS WITH CIRRHOSIS EXPERIENCE HIGHER ICU MORTALITY COMPARED TO NON-CIRRHOTIC PATIENTS WHICH CONTINUED WITH OR WITHOUT COVID-19 DESPITE CONTROLLING FOR ORGAN FAILURE SEVERITY
por: Park, Dan, et al.
Publicado: (2022)

Characterization of the Oral Fungal Microbiome (Mycobiome) in Healthy Individuals
por: Ghannoum, Mahmoud A., et al.
Publicado: (2010)

Characterizing patient-reported outcomes in veterans with cirrhosis
por: Rogal, Shari S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ffbjffvuforhvsqln0tq58m2l8